CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Meditrina Cyprus PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Meditrina Cyprus PLC
Anexartisias 1 kai Athinon 79
Ktirio Nora, 2os orofos, Gr. 205
Limassol, 3040  Cyprus Ticker: MEDTRNMEDTRN

Business Summary
Meditrina Cyprus PLC is a Cyprus-based company primarily engaged in investment activities. The Company's main activity is investments shares of other companies engaged in the trade of pharmaceutical products. The Company's subsidiaries include Synapsis Trading Ltd (Cyprus), Meditrina Bulgaria Ltd (Bulgaria), Medora EPE (Greece), Meditrina EPE (Greece), Meditrina Pharmaceuticals SRL (formerly Solartium Group SRL) (Romania) and Solartium Pharma SRL (Moldova).
(Source: F-4)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

General Information
Outstanding Shares: 45,000,000 (As of 6/30/2024)
Stock Exchange: CSE


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024